Tech Company Financing Transactions
NeuroGenetic Pharmaceuticals Funding Round
On 1/5/2012, NeuroGenetic Pharmaceuticals secured financing from AbbVie Biotech Ventures.
Transaction Overview
Company Name
Announced On
1/5/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The funding will expedite the development of our lead candidate, NGP 555, for the prevention of AD, including achieving our immediate goal of initiating clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
PO Box 2007
Rancho Santa Fe, CA 92067
USA
Rancho Santa Fe, CA 92067
USA
Phone
Email Address
Overview
NeuroGenetic Pharmaceuticals is a privately held biotech company founded in 2009 with worldwide exclusive rights to a platform of gamma-secretase modulators.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Comer
Browse more venture capital transactions:
Prev: 1/5/2012: Unwired Nation venture capital transaction
Next: 1/5/2012: Lithium Technologies venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs